AU2006248591B2 - Variants at Chr8q24.21 confer risk of cancer - Google Patents

Variants at Chr8q24.21 confer risk of cancer Download PDF

Info

Publication number
AU2006248591B2
AU2006248591B2 AU2006248591A AU2006248591A AU2006248591B2 AU 2006248591 B2 AU2006248591 B2 AU 2006248591B2 AU 2006248591 A AU2006248591 A AU 2006248591A AU 2006248591 A AU2006248591 A AU 2006248591A AU 2006248591 B2 AU2006248591 B2 AU 2006248591B2
Authority
AU
Australia
Prior art keywords
cancer
prostate cancer
haplotype
marker
allele
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2006248591A
Other languages
English (en)
Other versions
AU2006248591A1 (en
AU2006248591A9 (en
AU2006248591A2 (en
Inventor
Laufey Amundadottir
Julius Gudmundsson
Patrick Sulem
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Decode Genetics ehf
Original Assignee
Decode Genetics ehf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Decode Genetics ehf filed Critical Decode Genetics ehf
Publication of AU2006248591A1 publication Critical patent/AU2006248591A1/en
Publication of AU2006248591A9 publication Critical patent/AU2006248591A9/en
Publication of AU2006248591A2 publication Critical patent/AU2006248591A2/en
Application granted granted Critical
Publication of AU2006248591B2 publication Critical patent/AU2006248591B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2006248591A 2005-05-18 2006-05-18 Variants at Chr8q24.21 confer risk of cancer Ceased AU2006248591B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US68214705P 2005-05-18 2005-05-18
US60/682,147 2005-05-18
US79576806P 2006-04-28 2006-04-28
US60/795,768 2006-04-28
PCT/IS2006/000012 WO2006123369A1 (en) 2005-05-18 2006-05-18 Variants at chr8q24.21 confer risk of cancer

Publications (4)

Publication Number Publication Date
AU2006248591A1 AU2006248591A1 (en) 2006-11-23
AU2006248591A9 AU2006248591A9 (en) 2006-11-23
AU2006248591A2 AU2006248591A2 (en) 2006-11-23
AU2006248591B2 true AU2006248591B2 (en) 2012-02-23

Family

ID=36830953

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006248591A Ceased AU2006248591B2 (en) 2005-05-18 2006-05-18 Variants at Chr8q24.21 confer risk of cancer

Country Status (10)

Country Link
US (1) US20090317799A1 (enExample)
EP (1) EP1888772A1 (enExample)
JP (1) JP5227167B2 (enExample)
AU (1) AU2006248591B2 (enExample)
BR (1) BRPI0610794A2 (enExample)
CA (1) CA2608567A1 (enExample)
IL (1) IL187449A (enExample)
MX (1) MX2007014447A (enExample)
NZ (1) NZ563913A (enExample)
WO (1) WO2006123369A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2677994A1 (en) * 2007-02-07 2008-08-14 Decode Genetics Ehf. Genetic variants contributing to risk of prostate cancer
EP2164984A2 (en) * 2007-05-25 2010-03-24 Decode Genetics EHF. Genetic variants on chr 5pl2 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment
US8697360B2 (en) * 2007-11-30 2014-04-15 Decode Genetics Ehf. Genetic variants on CHR 11Q and 6Q as markers for prostate and colorectal cancer predisposition
US20090226912A1 (en) * 2007-12-21 2009-09-10 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with prostate cancer risk
US9732389B2 (en) 2010-09-03 2017-08-15 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with prostate cancer risk
US9534256B2 (en) 2011-01-06 2017-01-03 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with risk of aggressive prostate cancer
WO2013065072A1 (en) * 2011-10-30 2013-05-10 Decode Genetics Ehf Risk variants of prostate cancer
KR101944927B1 (ko) 2016-03-24 2019-02-07 서울대학교산학협력단 전립선암과 관련된 단일염기다형성 및 이를 이용한 유전 위험도 점수의 개발
KR20250074712A (ko) 2023-11-15 2025-05-28 주식회사 바스젠바이오 전립선암 발병의 위험도를 예측하기 위한 조성물 및 이를 이용한 방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
FI843529A0 (fi) 1983-01-10 1984-09-10 Gen Probe Inc Foerfarande foer detektering, identifiering och kvantitering av organismer och virus.
US5288611A (en) 1983-01-10 1994-02-22 Gen-Probe Incorporated Method for detecting, identifying, and quantitating organisms and viruses
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5424186A (en) 1989-06-07 1995-06-13 Affymax Technologies N.V. Very large scale immobilized polymer synthesis
US5288644A (en) 1990-04-04 1994-02-22 The Rockefeller University Instrument and method for the sequencing of genome
DE69132531T2 (de) 1990-12-06 2001-09-13 Affymetrix, Inc. (N.D.Ges.D.Staates Delaware) Verbindungen und ihre Verwendung in einer binären Synthesestrategie
US5384261A (en) 1991-11-22 1995-01-24 Affymax Technologies N.V. Very large scale immobilized polymer synthesis using mechanically directed flow paths
EP0655090B1 (en) 1992-04-27 2000-12-27 The Trustees Of Dartmouth College Detection of gene sequences in biological fluids
WO1999032644A2 (en) * 1997-12-22 1999-07-01 Genset Prostate cancer gene

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL accession no. AB137877 *
DATABASE EMBL accession no. G10216 *
DATABASE PROBE NCBI accession no. 607899 *
GUNDERSON et al (2005) Nature Genetics, vol.37, pages 549-554 *
Sato et al (1999) J Nat Cancer Inst, vol 91, pps 1574-1580 *

Also Published As

Publication number Publication date
JP2008539782A (ja) 2008-11-20
JP5227167B2 (ja) 2013-07-03
CA2608567A1 (en) 2006-11-23
AU2006248591A1 (en) 2006-11-23
BRPI0610794A2 (pt) 2010-11-09
AU2006248591A9 (en) 2006-11-23
NZ563913A (en) 2010-03-26
IL187449A (en) 2014-03-31
AU2006248591A2 (en) 2006-11-23
MX2007014447A (es) 2008-04-16
WO2006123369A1 (en) 2006-11-23
WO2006123369A8 (en) 2007-01-04
EP1888772A1 (en) 2008-02-20
US20090317799A1 (en) 2009-12-24
IL187449A0 (en) 2008-02-09

Similar Documents

Publication Publication Date Title
AU2007310412B2 (en) Cancer susceptibility variants on Chr8q24.21
AU2008256219B2 (en) Genetic variants on Chr 5p12 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment
EP2115171B1 (en) Genetic variants contributing to risk of prostate cancer
AU2009269540A1 (en) Genetic variants predictive of cancer risk in humans
EP2313525A2 (en) Genetic variants for breast cancer risk assessment
AU2008231425A1 (en) Genetic variants on Chr2 and Chr16 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment
IL187449A (en) And variants of chr8q24.21 as a cancer risk identification
EP2207894A2 (en) Sequence variants for inferring human pigmentation patterns
CA2556635A1 (en) Methods for diagnosing and characterizing breast cancer and susceptibility to breast cancer
WO2010131268A1 (en) Genetic variants for basal cell carcinoma, squamous cell carcinoma and cutaneous melanoma
WO2011095999A1 (en) Genetic variants for predicting risk of breast cancer
Al-Rohil et al. Molecular Studies Informing the Diagnosis of Melanocytic Lesions

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 23 NOV 2007

SREP Specification republished
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired